ARTICLE | Company News
Reports: Acorda exploring sale
January 5, 2018 11:35 PM UTC
Acorda Therapeutics Inc. (NASDAQ:ACOR) gained $2.50 (12%) to $23.55 on Friday after media reports that the company is exploring a possible sale. Acorda declined to comment...
BCIQ Company Profiles